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Abstract
Open-circuit mouthpiece ventilation (MPV) is a method of noninvasive ventilation, 
which can be used to provide full-time support, induce lung volume recruitment, 
increase cough efficacy, defer tracheostomy and possibly improve survival and quality 
of life in advanced-stage neuromuscular patients. MPV might also be applicable to other 
chronic respiratory diseases as well as in acute exacerbations of chronic obstructive pul-
monary disease and can also be employed for the extubation of unweanable neuromus-
cular patients. A candidate for MPV should be able to rotate his neck adequately, grab 
the mouthpiece with his lips and maintain sufficient control of the upper airway muscles. 
MPV is usually provided in the volume assisted-controlled mode with a tidal volume 
between 0.7 and 1.5 L, zero PEEP and backup rate set to the lower allowed value, allow-
ing the patient to define his own ventilatory pattern. The “low pressure” and “apnea” 
alarm should be switched off, if possible, or special setting adjustments should be used to 
prevent their activation. Comprehensive patient training and dedicated nursing time are 
important for the application of MPV. MPV is considered a safe method for the majority 
of the patients, but accidental mouthpiece loss is an important concern.
Keywords: noninvasive ventilation, tracheostomy, Duchenne muscular dystrophy, 
amyotrophic lateral sclerosis, home ventilation
1. Introduction: rationale for mouthpiece ventilation
Mouthpiece ventilation (MPV) is a unique method of respiratory support specifically intended 
to provide full-time ventilatory assistance mainly to patients with chronic ventilatory failure 
and limited or no ventilator-free breathing time [1–3]. Together with negative pressure venti-
lation, MPV is probably one of the oldest methods of noninvasive ventilatory support since it 
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was initially employed as an alternative to tracheostomy by poliomyelitis survivors 60 years 
ago [3]. However, it was the pioneering work of a few investigators over the last three decades, 
which popularized the use of MPV for the management of chronic ventilatory failure, and 
since 2013, several MPV modes have been incorporated into modern home ventilators [3, 4–10].
The main indication of MPV is the provision of full-time ventilatory support for patients with 
chronic progressive neuromuscular diseases (NMD). Many NMDs cause respiratory disease 
by involving inspiratory, expiratory and upper airway muscles, leading to sleep disordered 
breathing, reduced respiratory pump efficiency and weak cough [11, 12]. From the respira-
tory physician’s point of view, the most characteristic pathophysiologic trait of these NMDs 
is chronic alveolar hypoventilation which appears initially during the rapid eye movement 
sleep stage and extends eventually throughout all sleep stages before manifesting during 
daytime [13]. At advanced disease stages cough function is also severely impaired predis-
posing to respiratory infections and atelectasis [11, 12]. The institution of noninvasive posi-
tive pressure ventilation (NIV) for the support of the feeble respiratory muscles at the early 
stage of nocturnal hypoventilation is the mainstay of management of these patients and has 
been shown to improve survival, quality of sleep and quality of life [14–19]. However, as 
disease progresses and respiratory muscles continue to weaken, ventilatory requirements 
extend into the daytime. For patients with limited or no ventilator-free breathing time (e.g. 
ventilator use for > 16 or 20 hours per day), many practitioners would suggest transition to 
invasive ventilation via tracheostomy [20]. Importantly, an additional role of tracheostomy is 
the facilitation of secretion clearance given that at advanced disease stages cough flows are 
invariably reduced [11, 12]. In a European survey involving patients managed with home 
ventilation, patients with NMDs were the most likely to receive ventilatory support for a pro-
longed period (>6 years) and to have undergone tracheostomy procedures [21]. Nevertheless, 
long-term tracheostomies have been associated with several disadvantages including loss of 
voice, tube-related injuries, increased care-giver burden and disturbed self-image [2, 3, 9]. 
Although most patients would show preference toward a continued noninvasive mode of 
management [6, 22], standard nasal or oronasal masks are not suitable for this task since they 
commonly cause difficulties in eating, drinking and speech, sense of claustrophobia, limited 
field of vision, impaired social interaction and pressure lesions [1–3].
An alternative method for continuous noninvasive ventilator support is based on the 24 hour 
use of MPV or the combination of MPV during the daytime with nocturnal nasal or oronasal 
mask ventilation (MV). This method is complemented by ancillary strategies of which the most 
important are the “air-stacking” maneuver and the glossopharyngeal breathing (GPB) tech-
nique [1–3]. A good candidate for MPV should be able to rotate his neck and grab the mouth-
piece with his lips and also maintain good control of his upper airway muscles (Figure 1) [10]. 
MPV is usually delivered via a home ventilator in the volume-assist-control mode (VAC) with 
the tidal volume (Vt) commonly set between 0.7 and 1.5 L (to correct for air leaks), zero PEEP 
and a back-up respiratory rate ideally set to zero [1–3]. Therefore, the patient has the ability 
to define his pattern of breathing according to his own ventilatory needs by taking as many 
breaths as he requires and by modifying the quantity of leak [8].
Volume-target MPV facilitates the application of the “air-stacking” maneuver, which is 
performed by teaching the patient to stack consecutive volumes of air delivered from the 
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 ventilator until his lungs are maximally expanded. The maximum volume of air that can 
be held with a closed glottis is the patient’s maximum insufflation capacity (MIC) [23]. The 
role of air-stacking is to preserve lung function by effecting lung volume recruitment and to 
avert chest wall strictures and contractures in patients with NMDs who experience a progres-
sive decline in vital capacity (VC) [24, 25]. The difference MIC-VC depends directly on the 
integrity of glottic function and represents the amount of recruitable lung volume [24]. In a 
recent retrospective study of 151 patients with Duchenne muscular dystrophy (DMD), lung 
volume recruitment by air-stacking delayed the maximal VC decline by at least 5 years [26]. 
Other researchers have also reported a decrease in the rate of VC decline in patients with 
DMD [27] and a progressive increase in the MIC-VC difference, indicating a higher number of 
recruitable lung units [28]. In addition, lung expansion by air-stacking takes advantage of the 
increased respiratory system recoil pressure at high lung volumes to increase peak cough flow 
(PCF) and facilitate secretion clearance. In a group of 61 DMD patients, mean PCF increased 
from 137 to 236 L/min with the application of the air-stacking maneuver [29]. As an example, 
the application of air-stacking in a patient with amyotrophic lateral sclerosis (ALS) receiv-
ing MPV was associated with a MIC-VC difference of 0.4 L and an increase of PCF from 50 
to 200 L/min [30]. Therefore, the use of MPV in combination with the air-stacking maneuver 
supports daytime ventilatory function and improves cough efficacy deferring tracheostomy.
GPB is another strategy commonly taught to MPV users. This technique is based on the use of 
the tongue to gulp consecutive boluses of air, while the glottis remains closed after each gulp 
to retain the inhaled air. By imitating the effects of a deep breath, GPB induces lung volume 
Figure 1. A patient with non-bulbar amyotrophic lateral sclerosis making use of mouthpiece ventilation (from Agrafiotis 
et al. [30], after permission).
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recruitment and improves cough efficacy. In addition, GPB provides ventilator independency 
for patients with limited off-ventilator time and can be used as a rescue strategy in case of an 
accidental mouthpiece disconnection or ventilator failure [5, 6, 31].
During the last years, the use of MPV has also expanded to patients with other chronic respi-
ratory diseases such as chest wall diseases [32] as well as to acute exacerbations of chronic 
obstructive pulmonary disease (COPD) [33, 34]. Nevertheless, despite the increasing inter-
est in MPV, its application is limited to few centers specializing in noninvasive respiratory 
management [35]. Many practitioners are unfamiliar with its use, and several authors still 
consider tracheostomy as the most effective and secure method of ventilation for patients 
with advanced diseases [1].
In the rest of the chapter, we will present the evidence supporting the application of MPV for 
the management of respiratory disease and address several practical issues related to its use.
2. Evidence
2.1. Mouthpiece ventilation for full-time ventilatory support in neuromuscular 
patients
The application of MPV ventilation to 75 post-polio survivors with chronic respiratory fail-
ure was reported by Bach et al. [5]. All patients were using MPV as a major part of their 
respiratory support, but some (31%) were also using body respirators and the majority (88%) 
required full-time ventilator assistance. On average MPV was used for 1028 patient-years 
(14.8 years per person) for a total mortality of 1 death per 60.5 patient-years. Several of these 
MPV users married and some also joined the workforce.
Toussaint et al. [8] reported on 42 patients with DMD treated with MPV. Before introduced to 
MPV, all patients had diurnal hypercapnia by the end of the day while being treated optimally 
with nocturnal nasal ventilation. Survival at 1, 3, 5 and 7 years was 88, 66, 58 and 51%, respec-
tively. Importantly, the use of MPV was associated with stabilization of VC, despite a deteriora-
tion in respiratory muscle strength, while transcutaneous CO
2
 values improved. Some patients 
also reported improvements in dyspnea, appetite and swallowing. No important accidents or 
complications were observed over the 7-year follow-up period. VC was also preserved in a 
small cohort of 12 DMD patients who were prescribed MPV, a fact attributed to the concurrent 
use of lung volume recruitment strategies [36].
MPV was also compared to tracheostomy ventilation (TV) in 42 patients with DMD [9]. All 
tracheostomized patients (n = 16) used cuffless tubes and speaking valves connected in line 
with the ventilator circuit. While TV was associated with a higher incidence of tracheal inju-
ries, mucous hypersecretion and lung infections, MPV users had a slightly higher incidence of 
weight loss and need for enteral feeding. Causes of death did not roughly differ between the 
two groups, however one MPV user died as a result of loss of mouthpiece during wheelchair 
malfunction, while a TV patient died during an endoscopic procedure.
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Bedard and McKim [10] reported retrospectively on the use of MPV in patients with 
ALS. Of 37 patients in total, 27 were considered to be successful MPV users (consistent 
use > 1 month). The majority of the successful patients had less severe bulbar symptoms 
and demonstrated recruitable lung volume with MIC > VC. Importantly, all successful users 
experienced improved dyspnea scores and normalization of CO
2
 values. For this group 
of patients, FVC decreased as disease progressed, but MIC was relatively preserved and 
MIC-VC difference increased. The majority of them could effect a PCF > 180 L/min with lung 
volume recruitment throughout disease course. In addition, a PCF > 180 L/min at initiation 
of MPV in successful users was associated with significantly better mean survival (637 vs. 
240 days).
In addition, Khirani et al. [37] obtained questionnaires on quality of life issues from 30 neuromus-
cular MPV users. The majority of the patients reported reductions in dyspnea (73%) and fatigue 
(93%), and some of them also improvements in the ease of speech (43%) and swallowing (27%).
Overall, the above evidence indicates that MPV may defer tracheostomy, improve or stabilize 
clinically relevant lung function variables and possibly improve quality of life and confer a 
survival benefit to neuromuscular patients. The application of MPV seems relatively safe, 
although the possibility of mouthpiece loss is not a negligible concern. In addition, the con-
current use of other noninvasive aids, e.g. mechanical insufflation-exsufflation devices, might 
bias the interpretation of these studies. From this point of view, it is worth noting that in the 
study by Toussaint et al. [8], mechanical insufflation-exsufflation was available for only 7% of 
the patients. Nevertheless, further prospective studies are warranted to explore the impact of 
MPV on the outcomes of neuromuscular patients.
2.2. Mouthpiece ventilation for “unweanable” ventilator-dependent neuromuscular 
patients
MPV, sometimes combined with mechanical insufflation-exsufflation, has been successfully 
employed as a noninvasive method of weaning or removal of artificial tubes for patients with 
acute or chronic ventilatory failure, the majority of which had various NMDs. Many of these 
patients continued using MPV for several years [5, 6, 38]. A recent study [7] evaluated a sim-
plified protocol for the extubation of neuromuscular patients with no ventilator-free breath-
ing time. All patients (n = 157) who were normocapnic on invasive mechanical ventilation 
could maintain an SpO
2
 > 95% for 12 hours on room air and could reverse desaturations with 
the use of mechanical insufflation-exsufflation device were extubated to noninvasive nasal, 
oronasal or mouthpiece volume assisted-controlled ventilation. Intensive use of mechanical 
insufflation-exsufflation was provided after extubation. Patients using MPV could determine 
the amount of volume they required and, when possible, could wean themselves after extuba-
tion by taking gradually fewer breaths from the mouthpiece. This protocol effected extuba-
tion success (defined as discharge without reintubation) in 157 (98%) of the patients, of whom 
46% remained full-time ventilator-dependent. Although this study does not provide specific 
data with respect to each interface, it does exemplify the usefulness of mouthpiece for provid-
ing full-time ventilatory support without the requirement of an invasive tube.
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2.3. Mouthpiece ventilation in other chronic respiratory diseases
Nicolini et al. [32] recruited 18 mechanical ventilation-naive patients with severe kyphoscoliosis 
in a prospective 4-year study, which evaluated the impact of combined diurnal MPV and noc-
turnal MV on lung function, clinical outcomes and health-related quality of life. They observed 
significant improvements in spirometric indices, blood gases, static mouth pressures, ventila-
tory drive and polygraphic variables at 6 months. In addition, patients reported improvements 
in quality of life aspects as sleep, physical well-being, eating, leisure, self-confidence and mood. 
Mortality at the end of the study period was 22.2%. When compared to a historical group of 
kyphoscoliotic patients who received only nocturnal MV, survival was better for the combined 
group at 180, 360 and 720 days.
2.4. Mouthpiece ventilation in acute respiratory exacerbations
There is limited evidence on the effectiveness, safety and tolerance of MPV in the setting of 
acute respiratory failure. A randomized cross-over prospective physiologic study compared 
four different interfaces with various internal volumes including a mouthpiece with minimal 
internal volume in critically ill patients. No difference was noted in gas change and respira-
tory effort variables, but the mouthpiece was associated with more leaks and asynchronies 
and a significantly less comfort on a visual analogue scale [39]. In a cross-over study which 
compared short-term mouthpiece and face mask tolerance in a cohort of 27 intensive care 
unit (ICU) patients treated for acute respiratory failure, five patients were withdrawn due 
to poor tolerance of the mouthpiece. For the remaining subjects and their nurses, facemask 
was associated with a nonsignificant better comfort, but mouthpiece required a significantly 
higher nursing time. While oxygenation and blood gases significantly improved with both 
interfaces, only face masks were associated with a significantly lower respiratory rate [40].
Some of the above findings were challenged by more recent clinical studies. Glerant et al. 
[33] conducted a retrospective matched case-control study in which MPV was compared to 
nasal MV and standard medical care in 87 COPD patients admitted to a respiratory ICU due 
to acute hypercapnic exacerbation of mild severity (average pH 7.3). In both groups, assist-
control or pressure support modes were used. MPV was applied for 20 minutes every hour 
during the day and at less frequent intervals during the night. All MPV patients used a nose 
clips and had to hold the mouthpiece firmly and keep their mouth closed to avoid leaks. This 
study observed a nonsignificant lower intubation rate for MPV as compared to MV users (7 
vs. 14%) and similar improvements in blood gases although these changes occurred much 
later in the MPV group, a fact attributed to a longer learning period for these patients. Overall, 
the duration of NIV and ICU stay did not differ between these two groups.
The same question was revisited by a recent randomized controlled trial. Nicolini et al. [34] 
randomized 50 COPD patients presenting with acute exacerbation of mild-moderate sever-
ity (pH 7.25–7.30) to receive either nasal MV or MPV in the pressure support mode. No case 
of NIV failure was observed, and blood gas values showed similar trends while the dura-
tion of NIV and hospital stay did not differ between the two groups. Common complica-
tions included skin breakdown for the MV group and gastric distention for the MPV group. 
However, tolerance and device acceptability was better for the MPV group.
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Criticism for both the abovementioned studies focused on the use of nasal masks in the set-
ting of an acute exacerbation and the absence of long-term results. In addition, the study by 
Nicolini et al. [33] was underpowered to assess changes in blood gases, which was the pri-
mary outcome [41]. Pending the results of further investigations, MPV might be considered 
for COPD patients with a mild-moderate acute exacerbation who are intolerant of nasal or 
oronasal masks but retain a good level of consciousness and are not severely distressed in 
order to understand and apply this technique.
3. Practicalities in the application of mouthpiece ventilation
MPV is mainly indicated for neuromuscular patients with chronic ventilator failure when 
they develop daytime hypercapnia despite optimized nocturnal ventilatory support [8] or 
when they manifest deteriorating daytime breathlessness with increasing ventilator depen-
dence [10]. MPV can be performed with (1) a home life-support ventilator, (2) a single or a 
double-limb circuit, (3) various types of mouthpieces, and (4) adjustable support arm or cus-
tom-made straps to mount the mouthpiece close to the head for patients with advanced motor 
disabilities (Figure 2). The presence of an exhalation valve in the circuit is not a prerequisite 
for the delivery of MPV; however, it might be necessary for switching to nocturnal MV for 
patients using non-vented circuits. The ideal candidate should be able to grab the mouthpiece 
with his lips and adequately rotate his neck [10]. MPV can be combined with MV during sleep 
or applied 24 hours per day using specifically designed interfaces [6, 31].
3.1. Patient education
Most of the patients considered for MPV have already been using MV for several years. 
Nevertheless, the experience of MPV is quite different and some patients may feel uncomfort-
able and express reluctance to continue. The application of MPV requires active participation 
Figure 2. Setup for mouthpiece ventilation.
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from the patient, increased nursing time and longer periods of training. We generally instruct 
patients to “sip” from the mouthpiece, in a manner similar to drinking a beverage using a 
straw (Figure 1). When this maneuver is applied, the soft palate moves posterocaudally seal-
ing off the nasopharynx and minimizing nasal leaks. Importantly, the “sip” maneuver gener-
ates a higher negative pressure than maximum static inspiratory pressure, a fact that makes 
triggering easier for the frail neuromuscular patients [1].
3.2. Ventilator settings
The ventilator is usually set to the volume assisted-controlled mode with a Vt between 0.7 and 
1.5 L, while PEEP (or EPAP) and backup rate are set to zero or to the lowest manufacturer-
defined value. Recommendations on how to choose Vt and inspiratory time (Ti) are generally 
scarce [3]. If the patient is breathing comfortably while using MV, we begin with a similar Vt, 
albeit increased by 0.1–0.3 L to account for leaks and we commonly use a Ti at least as high as 1 s. 
Then we gradually increase Vt and/or Ti over several hours or days as much as tolerated. Many 
patients might have been using bilevel MV for many years before being introduced to volume-
targeted MPV. While in bilevel ventilation, peak inspiratory flow is determined by the preset 
pressure, respiratory resistance and patient effort [42] in traditional volume-targeted ventila-
tion inspiratory flow is ventilator-defined and is commonly delivered using a square waveform 
shape. Nevertheless, if the patient becomes severely breathless when switched to volume-tar-
geted MPV, the use of a decelerating flow shape which delivers higher peak inspiratory flows at 
the start of the breath might be considered [43] . Generally, the patient should be able to define 
his own ventilatory pattern by determining the number of breaths and the quantity of leak [8]. 
Some experts would choose to use a pressure, rather than a flow- regulated, inspiratory trig-
ger to avoid autotriggering [44]. However, despite the fact that in many new generation home 
ventilators only flow triggering is available, autotriggering with MPV seems to be less common 
than initially thought [37, 45]. Inspiratory trigger should be sensitive enough to reduce the work 
of breathing. However, since MPV users commonly fail to trigger the ventilator [45], a number 
of backup breaths could be set to ensure adequate ventilation and avert fatigue. On the other 
hand, machine-triggered breaths during patient disconnection from the mouthpiece might be a 
source of discomfort as a result of high flow on the user’s face [45]. Nevertheless, in some newer 
generation ventilators, triggering can be simply effected by creating a small negative pressure at 
the mouthpiece (“kiss-trigger”) [3, 37]. It must be noted that standard turbine ventilators are not 
designed to perform under conditions of rapidly changing load. A bench study which evalu-
ated five different modern home ventilators observed significant swings in Vt when conditions 
of disconnection and reconnection were experimentally reproduced [46].
3.3. Alarms
One of the major problems in open-circuit systems is the prevention of “low pressure” and 
“apnea” alarm activation. As a general rule, these alarms should be switched off when possible 
or set to the lowest sensitive value allowed by the manufacturer. Several new generation home 
ventilators are more versatile in alarm customization with some even incorporating specifi-
cally designed software for MPV [37, 45]. Nevertheless, the use of high resistance mouthpieces 
together with smart combinations of Vt and Ti may create a sufficient back pressure which will 
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prevent “low pressure” alarm activation, when the last cannot be switched off [37, 44];  practical 
recommendations for alarm customization for several home life-support ventilators have 
become recently available [45]. When ‘apnea’ alarming cannot be deactivated, a minimum of 
backup breaths should be set corresponding to the maximum allowed apnea time [44]. It should 
be noted, however, that at least in some types of ventilators, backup rate manipulation might 
also influence Ti, making alarm customization even more complicated [45].
3.4. Mouthpieces
There are a few types of mouthpieces available in the market nowadays, including angled 15 
and 22 mm mouthpieces, straw-like as well as lip-sealing interfaces or orthodontic bite plates 
(Figure 3). The performance of these interfaces in the delivery of MPV has been assessed in a 
limited number of studies. Khirani et al. [37] compared three different angled mouthpiece con-
figurations, a large mouthpiece (22 mm) and a small mouthpiece (15 mm) with and without a 
filter in a bench study which validated six different types of life-support home ventilators. The 
resistance was higher with the 15 mm mouthpiece with a filter, and this configuration was also 
Figure 3. A 15 mm mouthpiece.
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associated with a lower incidence of “low pressure” alarm activation. In another bench study, 
Ogna et al. [47] used four different home ventilators to compare the mechanical properties of 
various mouthpieces including a newly designed one. With respect to the most commonly 
used interfaces, respiratory resistance was lower with the 15 mm rigid-angled mouthpiece 
and higher with the straw mouthpiece. In volume-targeted modes with a Vt set to 1 L, both 
interfaces performed equally well across the different ventilators in delivering a volume close 
to the predetermined, while in pressure-targeted modes the effective pressure with the straw 
mouthpiece was slighter lower as a result of the increased resistance. The clinical implica-
tions of these findings remain unclear. For the time being, the choice of the interface should 
be tailored to the individual needs of each patient. An angled 15 mm mouthpiece seems to be 
a rational choice because its configuration increases resistance to the airflow preventing the 
activation of the “low pressure” alarm and in addition it is easier for the patient to grab [1]. If 
“low pressure” alarming persists, the addition of a filter to the circuit might be a simple and 
practical solution to the problem [37]. In addition, MPV can also be delivered during sleep 
with the use of specifically designed orthodontic bite plates or lip-sealing retention systems 
with attached Velcro straps to avoid disconnection. The use of these interfaces might cause 
desaturation, fragmented sleep and repeated arousals in a minority of the patients due to nasal 
leakage. Nasal pledges or clips can be applied to patients with significant nasal leaks [31].
3.5. Speaking and deglutition
Speaking is commonly problematic in patients with advanced respiratory disease as it requires 
higher than tidal inspiratory volumes and may slow the breathing rate causing breathlessness 
and fatigue [48]. If a patient on MPV needs to speak, he must take a large breath from the 
mouthpiece and then speak while expiration is driven by the expiratory muscles and the 
respiratory system recoil pressure. Nevertheless, speaking with the use of the mouthpiece 
might be associated with longer pauses (in order to breath in) and difficulties in choosing the 
right strategy for mouthpiece positioning and use [48].
Breathing and swallowing are normally competitive procedures and their coordination is dis-
rupted in respiratory disease with respiration taking precedence over swallowing. Swallowing 
in neuromuscular patients is characterized by piecemeal deglutition, increased time to swal-
low a bolus and an increased number of swallows during inspiration. The institution of posi-
tive pressure ventilation stabilizes breathing and improves swallowing performance [49]. The 
practice of MPV should theoretically contribute to the restoration of swallowing and breath-
ing coordination as users have to alternate between taking deep breaths from the mouthpiece 
and swallowing. In addition, MPV should also maintain the supraglottic pressure required 
for effective swallowing, while the high inspired volumes improve cough efficacy provid-
ing protection against aspiration [48]. Nevertheless, as disease progresses and ventilator-free 
time is reduced, less time is available for swallowing, while the presence of food in the mouth 
and in the pharynx does not allow patients to breath in safely. To deal with this problem, 
some patients use the ventilator to perform air-stacking in order to increase lung volume and 
afford longer periods of apnea without breathlessness [9]. Although weight loss and feeding 
 problems in MPV users have been reported [9], it is not clear whether these should be attrib-
uted to the interface per se or to disease progression and increasing breathlessness.
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It should be noted that a disconnection from the mouthpiece for eating and speaking might 
compromise effective gas exchange. In a small study including eight MPV users who were 
monitored with polygraghy during daily activities, most of the patients could speak and eat 
without ventilator assistance; however, prolonged disconnections (>3 min) (e.g. during meals) 
were associated with significant drops in SpO
2




A few complications associated with MPV have been so far reported, of which mouthpiece 
loss is the most important [9]. This complication can be avoided if the mouthpiece’s position 
is secured using specifically designed support arms or customary-made straps. Fixation of 
the mouthpiece on the shoulders allows the interface to follow the patient’s movements [8]. 
In addition, MPV users could be taught the technique of GPB to maintain ventilator inde-
pendency in case of accidental mouthpiece loss [6, 31]. Other complications include saliva-
tion, aerophagia, abdominal distention and orthodontic problems [1, 2, 6, 51]. There are no 
available data on the management of excessive salivation in mouthpiece users. For more 
severe cases the administration of an anticholinergic agent such as amitriptyline might be 
considered [9, 52]. Aerophagia and abdominal distention are common complications of non-
invasive ventilatory support and have been associated with respiratory distress and ventila-
tor dependence [51]. For patients with gastrostomies, unclamping the gastric tube to “burp 
out” the air is a quick method to effect symptom relief. Sometimes a nasogastric or a rectal 
rube (for patients with colonic distention) might also be helpful [51]. For patients with per-
sistent symptoms switching to pressure-targeted ventilation could be an option, although 
this mode is not suitable for the application of lung volume recruitment and air-stacking 
maneuvers. If the patient is maintained on a volume-targeted mode, setting a lower pressure 
limit to effect secondary pressure cycling is an alternative option. Vomiting and aspiration 
as a result of gastric distention as well as pneumothorax have been so far theoretical con-
cerns, but they represent potentially life-threatening events [4, 53]. Orthodontic complica-
tions are not uncommon in long-term users; however, they pose mostly an esthetic rather 
than a functional concern and specifically designed orthodontic interfaces have become 
available in the market [6, 31, 53]. Patients on MPV and full-time ventilator dependence 
can safely undergo dental procedures using nasal interfaces as long as oxygen saturation is 
monitored and oxygen or sedatives are avoided [54].
4. Conclusion
MPV is a “re-discovered” method of noninvasive ventilation that can be used to provide full-
time ventilatory support, recruit lung volume, improve cough efficacy, defer tracheostomy 
and possibly improve survival and quality of life in neuromuscular patients. MPV might 
also be beneficial for patients with other chronic respiratory diseases or in acute COPD 
hypercapnic exacerbation. The successful application of MPV requires careful selection of 
patient, interface, ventilator and alarm settings, increased nursing time and comprehensive 
patient training.
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